A Mediterranean dietary intervention in persons at high risk of colon cancer: recruitment and retention to an intensive study requiring biopsies.

[1]  A. Linos,et al.  The mediterranean diet in cancer prevention: a review. , 2011, Journal of medicinal food.

[2]  R. Bostick,et al.  Semiparametric estimation for joint modeling of colorectal cancer risk and functional biomarkers measured with errors , 2011, Biometrical journal. Biometrische Zeitschrift.

[3]  D. Bowen,et al.  Scientific Bias Arising from Sampling, Selective Recruitment, and Attrition: The Case for Improved Reporting , 2011, Cancer Epidemiology, Biomarkers & Prevention.

[4]  L. Serra-Majem,et al.  Association Between the Mediterranean Diet and Cancer Risk: A Review of Observational Studies , 2010, Nutrition and cancer.

[5]  T. Wadden,et al.  Weight and Metabolic Outcomes After 2 Years on a Low-Carbohydrate Versus Low-Fat Diet , 2010, Annals of Internal Medicine.

[6]  Ananda Sen,et al.  Design of a Mediterranean exchange list diet implemented by telephone counseling. , 2008, Journal of the American Dietetic Association.

[7]  Z. Djuric,et al.  Effects of High Fruit-Vegetable and/or Low-Fat Intervention on Breast Nipple Aspirate Fluid Micronutrient Levels , 2007, Cancer Epidemiology Biomarkers & Prevention.

[8]  Sadao Suzuki,et al.  Plasma carotenoid, alpha-tocopherol and retinol concentrations and risk of colorectal adenomas: A case-control study in Japan. , 2005, Cancer letters.

[9]  J. González,et al.  Converging patterns of colorectal cancer mortality in Europe. , 2005, European journal of cancer.

[10]  J. Weissfeld,et al.  Carotenoids, vitamin A and risk of adenomatous polyp recurrence in the polyp prevention trial , 2004, International journal of cancer.

[11]  A. P. Simopoulos.  The traditional diet of Greece and cancer , 2004, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[12]  G. Davı̀,et al.  Inflammation, insulin resistance, and obesity , 2004, Current atherosclerosis reports.

[13]  M. Garaulet,et al.  Site-specific differences in the fatty acid composition of abdominal adipose tissue in an obese population from a Mediterranean area: relation with dietary fatty acids, plasma lipid profile, serum insulin, and central obesity. , 2001, The American journal of clinical nutrition.

[14]  C. Rock,et al.  Colonic mucosal prostaglandin E2 and cyclooxygenase expression before and after low aspirin doses in subjects at high risk or at normal risk for colorectal cancer. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[15]  John D. Potter,et al.  Food, nutrition and the prevention of cancer : a global perspective , 2001 .

[16]  D. Alberts,et al.  Physical activity, body mass index, and prostaglandin E2 levels in rectal mucosa. , 1999, Journal of the National Cancer Institute.

[17]  G. Omenn,et al.  Strategies for recruitment to a population-based lung cancer prevention trial: the CARET experience with heavy smokers. Beta-Carotene and Retinol Efficacy Trial. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[18]  C. Rock,et al.  Suppression of human colorectal mucosal prostaglandins: determining the lowest effective aspirin dose. , 1997, Journal of the National Cancer Institute.

[19]  J. Knowelden,et al.  Cancer Epidemiology and Prevention , 1976, British Journal of Cancer.

[20]  C. Ulrich,et al.  Mailing strategies and recruitment into an intervention trial of the exercise effect on breast cancer biomarkers. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[21]  P. Greenwald.  Cancer risk factors for selecting cohorts for large‐scale chemoprevention trials , 1996, Journal of cellular biochemistry. Supplement.

[22]  V. Steele,et al.  Strategies for phase II cancer chemoprevention trials: Cervix, endometrium, and ovary , 1995, Journal of cellular biochemistry. Supplement.